Table 2.
Effect of the Adherence and Knowledge Exchange heart disease medicines (TAKEmeds) intervention on the primary outcome: medication adherence.
|
Medication adherence |
Baseline |
Follow-up |
Unadjusted ORa
(95% CI) |
P value |
Adjustedb OR (95% CI) |
P value |
|
| Combined, n (%) | |||||||
| High | 107 (61.5) | 121 (69.5) | 1.74 (1.09-2.78) | .02 | 1.80 (1.14-2.85) | .01 | |
| Middle | 44 (25.3) | 44 (25.3) | |||||
| Low | 23 (13.2) | 9 (5.2) | |||||
| Shanghai, n (%) | |||||||
| High | 61 (64.9) | 47 (50.0) | 0.71 (0.42-1.22) | .22 | 0.61 (0.33-1.12) | .11 | |
| Middle | 19 (20.2) | 38 (40.4) | |||||
| Low | 14 (14.9) | 9 (9.6) | |||||
| Hainan, n (%) | |||||||
| High | 46 (57.5) | 74 (92.5) | 12.85 (4.62-35.76) | <.001 | 14.68 (5.20-41.45) | <.001 | |
| Middle | 25 (31.3) | 6 (7.5) | |||||
| Low | 9 (11.3) | 0 | |||||
aOR: Odds ratio.
bAdjusted for age, gender, region, heart disease type, heart disease diagnosis time (< or >1 year), hypertension, diabetes status, and number of medications taken.